Page last updated: 2024-08-21

pyrazines and Vasculitis

pyrazines has been researched along with Vasculitis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Besada, E; Koldingsnes, W; Nossent, JC; Vik, A1
Claxton, D; Fink, L; Talamo, G; Tricot, G; Zangari, M1
Gunsilius, E; Mitterer, M; Spizzo, G1
Altavilla, G; Arrigo, C; Naro, C; Pitini, V1
Alomar, A; Dalmau, J; Fernández-Figueras, MT; Garcia-Navarro, X; Puig, L; Roe, E1

Reviews

2 review(s) available for pyrazines and Vasculitis

ArticleYear
Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review.
    International journal of hematology, 2013, Volume: 97, Issue:6

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Boronic Acids; Bortezomib; Cryoglobulinemia; Female; Humans; Pyrazines; Rituximab; Treatment Failure; Treatment Outcome; Vasculitis

2013
Bortezomib-associated cutaneous vasculitis.
    The British journal of dermatology, 2007, Volume: 157, Issue:4

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Eruptions; Female; Humans; Male; Middle Aged; Protease Inhibitors; Pyrazines; Skin Diseases, Vascular; Vasculitis

2007

Other Studies

3 other study(ies) available for pyrazines and Vasculitis

ArticleYear
Response to bortezomib in refractory type I cryoglobulinemia.
    American journal of hematology, 2008, Volume: 83, Issue:11

    Topics: Boronic Acids; Bortezomib; Cryoglobulinemia; Humans; Male; Middle Aged; Protease Inhibitors; Pyrazines; Vasculitis

2008
Bortezomib for the treatment of refractory Type-1 cryoglobulinaemia.
    British journal of haematology, 2010, Volume: 150, Issue:2

    Topics: Adult; Aged; Boronic Acids; Bortezomib; Cryoglobulinemia; Humans; Male; Protease Inhibitors; Pyrazines; Skin Diseases, Vascular; Vasculitis

2010
Severe pulmonary complications after bortezomib treatment for multiple myeloma: an unrecognized pulmonary vasculitis?
    Leukemia research, 2007, Volume: 31, Issue:7

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Lung Diseases; Male; Middle Aged; Multiple Myeloma; Pleural Effusion; Pyrazines; Respiratory Insufficiency; Vasculitis

2007